Miaoshou Doctor closes RMB600m Series D1 round

Miaoshou Doctor announced the completion of a 600 million yuan Series D1 round of financing, jointly invested by Qiming Venture Capital, INCE Capital Partners, Sequoia Capital, CITIC Securities, Index Capital China and other institutions.

Miaoshou Doctor announced the completion of a 600 million yuan Series D1 round of financing, jointly invested by Qiming Venture Capital, INCE Capital Partners, Sequoia Capital, CITIC Securities, Index Capital China and other institutions.

Proceeds from the financing round will be used for the joint development of the “medicine-pharmaceutical-insurance” business of Miaoshou Doctor internet hospital, medical technology, prescription circulation and management, and health insurance.

Established in 2015, Miaoshou Doctor is a developer of patient management and communication platform for healthcare professionals/patients to manage post-diagnosis outcomes. The platform allows doctors to actively follow up with their patient’s health through additional counseling and prescriptions.

In response to the investment, Hu Xubo, the managing partner of Qiming Venture Partners, said that Miaoshou Doctor has been exploring the use of Internet, medical and insurance big data to improve the efficiency of medical services and reduce the cost of medical treatment and medication.

Since its establishment, the platform’s core businesses have continued to develop and continuously improve the quality of services, providing a large number of customers with better medical experiences and medical security.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/17/miaoshou-doctor-closes-rmb600m-series-d1-round/.

Leave a Reply

Please Login to Comment